Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSILO Pharma Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q2 2026 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q3 2026 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q4 2026 | 1 | -$0.20 | -$0.20 | -$0.20 |
SILO Pharma Inc Earnings Date And Information
SILO Pharma Inc last posted its earnings results on Monday, March 25th, 2024. The company reported $-0.36 earnings per share for the quarter, missing analysts' consensus estimates of $-0.2 by $0.16. The company had revenue of 18.03 K for the quarter and had revenue of 72.10 K for the year. SILO Pharma Inc has generated $-1 earnings per share over the last year ($-0.5 diluted earnings per share) and currently has a price-to-earnings ratio of -1.33. SILO Pharma Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
SILO Pharma Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/27/2026 | Q4 2025 | N/A | -$0.07 | N/A | N/A | $18.03 K |
| 11/13/2025 | Q3 2025 | N/A | -$0.12 | N/A | N/A | $18.03 K |
| 08/13/2025 | Q2 2025 | N/A | -$0.19 | N/A | N/A | $18.03 K |
| 05/09/2025 | Q1 2025 | N/A | -$0.23 | N/A | N/A | $18.03 K |
| 03/28/2025 | Q4 2024 | N/A | -$0.39 | N/A | $18.00 K | $18.03 K |
| 11/12/2024 | Q3 2024 | N/A | -$0.22 | N/A | $18.00 K | $18.03 K |
| 08/13/2024 | Q2 2024 | N/A | -$0.31 | N/A | $18.00 K | $18.03 K |
| 05/13/2024 | Q1 2024 | N/A | -$0.28 | N/A | N/A | $18.03 K |
| 03/25/2024 | Q4 2023 | -$0.20 | -$0.39 | -0.19 | N/A | $18.03 K |
| 11/13/2023 | Q3 2023 | -$0.21 | -$0.21 | 0 | N/A | $18.03 K |
| 08/11/2023 | Q2 2023 | N/A | -$0.32 | N/A | N/A | $18.03 K |
| 05/12/2023 | Q1 2023 | N/A | -$0.29 | N/A | N/A | $18.03 K |
| 03/24/2023 | Q4 2022 | N/A | -$0.78 | N/A | N/A | $18.03 K |
| 11/10/2022 | Q3 2022 | N/A | -$0.51 | N/A | N/A | $18.03 K |
| 08/01/2022 | Q2 2022 | N/A | -$0.41 | N/A | N/A | $18.03 K |
| 05/13/2022 | Q1 2022 | N/A | -$0.31 | N/A | N/A | $18.03 K |
| 03/28/2022 | Q4 2021 | N/A | -$0.57 | N/A | N/A | $18.03 K |
| 11/10/2021 | Q3 2021 | N/A | $3.16 | N/A | N/A | $18.03 K |
| 08/13/2021 | Q2 2021 | N/A | -$0.24 | N/A | N/A | $18.03 K |
| 05/17/2021 | Q1 2021 | N/A | -$0.55 | N/A | N/A | $17.19 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
SILO Pharma Inc Earnings: FAQ's
The conference call for SILO Pharma Inc's latest earnings report can be listened to online.
The conference call transcript for SILO Pharma Inc's latest earnings report can be read online.
SILO Pharma Inc (:SILO) has a recorded annual revenue of $72.10 K.
SILO Pharma Inc (:SILO) has a recorded net income of $-4,227,698.SILO Pharma Inc has generated $-0.5 earnings per share over the last four quarters.
SILO Pharma Inc (:SILO) has a price-to-earnings ratio of -1.33 and price/earnings-to-growth ratio is -0.02.